Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, April 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Diagnosis of Bladder Cancer and Prediction of Survival by Urinary Metabolomics
Bladder cancer seems to be ideal for urinary metabolomics-based diagnosis, as urine can directly contact the cancer lesion in the bladder.
A Metabolomic Perspective on Coeliac Disease
Metabolomics has proved to be a useful complement for the characterization of several physiological and pathological conditions and offers promises as a clinical tool.
Underlying Genetics and Marker For Stroke Discovered
NIH-funded findings point to new potential strategies for disease prevention, treatment.
BIOCRATES Test Kit Helps Develop First Metabolomics-Based Blood Test for Alzheimer’s
The test is capable of predicting, with 90% accuracy, the risk of Alzheimer’s disease 2–3 years before it has actually become clinically manifest.
The Role of Mass Spectrometry in the "Omics" Era
The tremendous developments of the MS technology and concurrent gene sequencing efforts have made the “-omic” revolution possible.
Metabolomics: Taking Aim at Diabetic Kidney Failure
Krolewski and his Joslin colleagues search for better ways of predicting which diabetic people are at risk for ESRD.
Omega-3 Fatty Acids have Wider Range of Biological Impacts
Study explored the challenges the liver faces from the “Western diet” that increasingly is linked to liver inflammation, fibrosis, cirrhosis and sometimes liver failure.
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Fatty Liver Disease Reversed in Mice
Epilepsy drug also shown to decrease obesity-related blood sugar levels.
GW Receives up to $14.6M to Develop Method for Characterizing Security Threats
The researchers are tasked with reducing to 30 days a process that can sometimes take years or even decades.

Novel Biomarker Discovery Using Metabolomics
Felice de Jong, Director, Metabolon Inc. speaking at the European Biomarkers Summit 2006.

LC/MS/MS Solutions for Targeted and Non-Targeted Small Molecule and Protein Biomarker Discovery, Verification and Validation
Henri Snijders, European Marketing Manager Small Molecules, Applied Biosystems speaking at the European Biomarkers Summit 2006.

Novel Approach to Active Metabolite Identification Allowing Early Access to Metabolic Profiling Studies to Improve Lead Candidate Selection
Dr. Danny van Elswijk, Screening Director, Kiadis BV, speaking at Advances in Metabolic Profiling 2005.

Identification of Major Metabolism Regulators from Metabolic Profiles
Dr. Anton Yuryev, Executive Director of Application Science, Ariadne Genomics Inc., speaking at Advances in Metabolic Profiling 2005.

Metabolomics in the Drug Discovery Process: Interactions With Other -omes
Dr Julian L. Griffin, University of Cambridge speaking at Advances in Metabolomic Profiling 2005.

Predicting Clinical Resistance to Gleevec Treatment by in vitro Applied Stable Isotope-based Dynamic Metabolic Profiling
Laszlo G. Boros, Los Angeles Biomedical Research Institute at UCLA and SIDMAP, LLC, speaking at Advances in Metabolic Profiling 2005

Metabolic Profiles and Biomarkers for Detection and Prediction of Drug Effects
Hans Senn of F. Hoffmann-La Roche AG speaking at Advances in Metabolic Profiling 2005.

Predicting the Safety of FDA Regulated Products with Metabolomics
Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.

The Application of Metabolic Profiling Techniques in Biomarker Discovery in Drug R&D
Dr. Ina Schuppe Koistinen, AstraZeneca R&D speaking at Advances in Metabolic Profiling 2005

<< 1 2 3 4 5 6 7 >>
Showing Results 61 - 70 of 70
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv